Cheng-Cheng Hwang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cheng-Cheng Hwang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Liang-Che Chang
Department of Pathology, Chang-Gung Memorial Hospital and University, Keelung Branch, Keelung 20401, Taiwan
2 shared publications - Cheng-Ming Luo
Department of Otolaryngology - Head and Neck Surgery, Chang Gung Memorial Hospital, Keelung City, Taiwan
1 shared publication - Hui-Ping Chein
College of Medicine, Chang Gung University, Tao-Yuan, Taiwan
1 shared publication - Jim-Ray Chen
Department of Pathology, Chang Gung Memorial Hospital, Keelung 204, Taiwan
1 shared publication - Shih-Wei Yang
Department of Otolaryngology‐Head and Neck Surgery Chang Gung Memorial Hospital Keelung Taiwan
1 shared publication - Siu-Chung Chen
Department of Radiology, Chang Gung Memorial Hospital, Keelung, Taiwan
1 shared publication
Latest Publications
- Open Access
- 15 May 2015
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-8
Clinical characteristics of narrow-band imaging of oral erythroplakia and its correlation with pathology
To analyze the clinical application of endoscope with narrow-band imaging (NBI) system in detecting high-grade dysplasia, carcinoma in situ, and carcinoma in oral erythroplakia. The demographic, histopathological data, and NBI vasculature architectures of patients receiving surgical intervention for oral erythroplakia were retrospectively reviewed and analyzed statistically. A total of 72 patients, including 66 males and 6 females, with mean age of 54.6 ± 11.2 years, were enrolled. The odds ratio of detecting high-grade dysplasia, carcinoma in situ, and carcinoma by twisted elongated morphology and destructive pattern of intraepithelial microvasculature was 15.46 (confidence interval 95 %: 3.81–72.84), and the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 80.95 %, 78.43 %, 60.71 %, 90.91 %, and 79.17 %, respectively, which were significantly better than other two established NBI criteria (p < 0.001). Twisted, elongated, and destructive patterns of intraepithelial papillary capillary loop of NBI images are indicators for high-grade dysplasia, carcinoma in situ, and invasive carcinoma in oral erythroplakia.
- 15 May 2015
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-8
Open AccessClinical characteristics of narrow-band imaging of oral erythroplakia and its correlation with pathology
To analyze the clinical application of endoscope with narrow-band imaging (NBI) system in detecting high-grade dysplasia, carcinoma in situ, and carcinoma in oral erythroplakia. The demographic, histopathological data, and NBI vasculature architectures of patients receiving surgical intervention for oral erythroplakia were retrospectively reviewed and analyzed statistically. A total of 72 patients, including 66 males and 6 females, with mean age of 54.6 ± 11.2 years, were enrolled. The odds ratio of detecting high-grade dysplasia, carcinoma in situ, and carcinoma by twisted elongated morphology and destructive pattern of intraepithelial microvasculature was 15.46 (confidence interval 95 %: 3.81–72.84), and the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 80.95 %, 78.43 %, 60.71 %, 90.91 %, and 79.17 %, respectively, which were significantly better than other two established NBI criteria (p < 0.001). Twisted, elongated, and destructive patterns of intraepithelial papillary capillary loop of NBI images are indicators for high-grade dysplasia, carcinoma in situ, and invasive carcinoma in oral erythroplakia.
- Open Access
- 5 October 2011
- Published by Springer Nature in Diagnostic Pathology
- Vol. 6 (1) , 96
De novo malignant solitary fibrous tumor of the kidney
The kidney is a relatively infrequent site for solitary fibrous tumor (SFT). Among the previously reported cases, only two cases of malignant renal SFT developing via dedifferentiation from a pre-existing benign SFT have been reported. Here we reported a case of de novo malignant renal SFT clinically diagnosed as renal cell carcinoma in a 50-year-old woman. The tumor was circumscribed but unencapsulated and showed obvious hemorrhagic necrosis. Microscopically, the tumor was composed of patternless sheets of alternating hypercellular and hypocellular areas of spindle cells displaying mild to moderate nuclear atypia, frequent mitoses up to 8 per 10 high power fields, and a 20% Ki-67 proliferative index. Immunohistochemical studies revealed reactivity for CD34, CD99 and vimentin, with no staining for all other markers, confirming the diagnosis of SFT. No areas of dedifferentiation were seen after extensive sampling. Based on the pathologic and immunohistochemical features, a diagnosis of de novo malignant renal SFT was warranted. Our report expands the spectrum of malignant progression in renal SFTs. Even though this patient has been disease-free for 30 months, long-term follow-up is still mandatory.
- 5 October 2011
- Published by Springer Nature in Diagnostic Pathology
- Vol. 6 (1) , 96
Open AccessDe novo malignant solitary fibrous tumor of the kidney
The kidney is a relatively infrequent site for solitary fibrous tumor (SFT). Among the previously reported cases, only two cases of malignant renal SFT developing via dedifferentiation from a pre-existing benign SFT have been reported. Here we reported a case of de novo malignant renal SFT clinically diagnosed as renal cell carcinoma in a 50-year-old woman. The tumor was circumscribed but unencapsulated and showed obvious hemorrhagic necrosis. Microscopically, the tumor was composed of patternless sheets of alternating hypercellular and hypocellular areas of spindle cells displaying mild to moderate nuclear atypia, frequent mitoses up to 8 per 10 high power fields, and a 20% Ki-67 proliferative index. Immunohistochemical studies revealed reactivity for CD34, CD99 and vimentin, with no staining for all other markers, confirming the diagnosis of SFT. No areas of dedifferentiation were seen after extensive sampling. Based on the pathologic and immunohistochemical features, a diagnosis of de novo malignant renal SFT was warranted. Our report expands the spectrum of malignant progression in renal SFTs. Even though this patient has been disease-free for 30 months, long-term follow-up is still mandatory.